Soley Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$200M
- Investors
-
9
Soley Therapeutics General Information
Description
Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases. The company offers an automated image-based technology using AI and machine learning to interpret cellular responses to compounds, enabling pharmaceutical and biotechnology researchers to identify drug candidates and improve decision-making across development programs.
Contact Information
Website
www.soleytherapeutics.comCorporate Office
- 1 Corporate Drive
- South San Francisco, CA 94080
- United States
Corporate Office
- 1 Corporate Drive
- South San Francisco, CA 94080
- United States
Soley Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 08-Jan-2026 | $200M | Completed | Product Development | ||
| 2. Early Stage VC (Series B) | 15-Apr-2022 | Completed | Product Development | |||
| 1. Early Stage VC (Series A) | 18-Dec-2020 | $20M | $20M | Completed | Product Development |
Soley Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 4,000,000 | $0.001000 | 8% | $5 | $5 | 1x | $5 | 13.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Soley Therapeutics Patents
Soley Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026217529-A1 | Celastrol combinations for the treatment of cancer | Pending | 08-Apr-2025 | ||
| WO-2026213291-A1 | Substituted heterocyclic modulators for the treatment of cancer | Pending | 02-Apr-2025 | ||
| WO-2025255134-A1 | Piperazinone based modulators for the treatment of disease | Pending | 04-Jun-2024 | ||
| WO-2025255014-A1 | Substituted heterocyclic modulators for the treatment of disease | Pending | 03-Jun-2024 | ||
| EP-4695236-A1 | Substituted phenyl-piperazinyl based modulators for the treatment of disease | Inactive | 14-Apr-2023 | C07D401/12 |
Soley Therapeutics Signals
Soley Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HRTG Partners | Fund of Funds | Minority | ||
| Qudit | Venture Capital | Minority | ||
| RWN Management | Family Office | Minority | ||
| Surveyor Capital | Hedge Fund | Minority | ||
| Artisanal Ventures | Venture Capital | Minority |
Soley Therapeutics FAQs
-
When was Soley Therapeutics founded?
Soley Therapeutics was founded in 2020.
-
Where is Soley Therapeutics headquartered?
Soley Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Soley Therapeutics?
Soley Therapeutics has 39 total employees.
-
What industry is Soley Therapeutics in?
Soley Therapeutics’s primary industry is Drug Discovery.
-
Is Soley Therapeutics a private or public company?
Soley Therapeutics is a Private company.
-
What is the current valuation of Soley Therapeutics?
The current valuation of Soley Therapeutics is .
-
What is Soley Therapeutics’s current revenue?
The current revenue for Soley Therapeutics is .
-
How much funding has Soley Therapeutics raised over time?
Soley Therapeutics has raised $290M.
-
Who are Soley Therapeutics’s investors?
HRTG Partners, Qudit, RWN Management, Surveyor Capital, and Artisanal Ventures are 5 of 9 investors who have invested in Soley Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process